Josh Riggs - Net Worth and Insider Trading
Josh Riggs Net Worth
The estimated net worth of Josh Riggs is at least $8,535 dollars as of 2024-11-29. Josh Riggs is the CEO and President of OncoCyte Corp and owns about 3,505 shares of OncoCyte Corp (OCX) stock worth over $8,535. Details can be seen in Josh Riggs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Josh Riggs has not made any transactions after 2024-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Josh Riggs
Josh Riggs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Josh Riggs owns 1 companies in total, including OncoCyte Corp (OCX) .
Click here to see the complete history of Josh Riggs’s form 4 insider trades.
Insider Ownership Summary of Josh Riggs
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OCX | OncoCyte Corp | 2024-04-11 | Interim CEO |
Josh Riggs Latest Holdings Summary
Josh Riggs currently owns a total of 1 stock. Josh Riggs owns 3,505 shares of OncoCyte Corp (OCX) as of April 11, 2024, with a value of $8,535.
Latest Holdings of Josh Riggs
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OCX | OncoCyte Corp | 2024-04-11 | 3,505 | 2.44 | 8,535 |
Holding Weightings of Josh Riggs
Josh Riggs Form 4 Trading Tracker
According to the SEC Form 4 filings, Josh Riggs has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 3,390 shares on April 11, 2024, which cost Josh Riggs around $10,001.
Insider Trading History of Josh Riggs
- 1
Josh Riggs Trading Performance
GuruFocus tracks the stock performance after each of Josh Riggs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Josh Riggs is 6.24%. GuruFocus also compares Josh Riggs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Josh Riggs within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Josh Riggs's insider trading performs compared to the benchmark.
Josh Riggs Ownership Network
Josh Riggs Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Josh Riggs is the Interim CEO of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , other: Former Director John Peter Gutfreund , and 10 percent owner Pura Vida Investments, Llc .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Josh Riggs made 1 insider transaction in OncoCyte Corp (OCX) with a net purchase of 3,390. Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 3,735,339 shares made by Broadwood Partners Lp , a net purchase of 33,898 shares made by Andrew Arno , and a net purchase of 33,670 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 1,349,009 shares, with a net purchase of 1,349,009 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,807,797 shares were bought by its insiders, resulting in a net purchase of 3,807,797 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Josh Riggs Mailing Address
Above is the net worth, insider trading, and ownership report for Josh Riggs. You might contact Josh Riggs via mailing address: 15 Cushing, Irvine Ca 92618.